{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:29:16Z","timestamp":1794540556552,"version":"4.9.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Ministry of Health, Labour"},{"name":"Welfare of Japan"},{"name":"H30-menneki-shitei-002","award":["22FE0201"],"award-info":[{"award-number":["22FE0201"]}]},{"name":"UCB-Japan"},{"name":"UCB Japan Co., Ltd","award":["JP21ek0410086"],"award-info":[{"award-number":["JP21ek0410086"]}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Asahi Kasei Pharma Co."},{"name":"Ayumi Pharmaceutical Co."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare treatment outcomes in patients with late-onset RA (LORA) and younger-onset RA (YORA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed patients diagnosed with early RA (disease duration &amp;lt; 2\u2009years) between 2000 and 2016 in the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) cohort. Patients were categorized into LORA (onset at \u226565\u2009years) and YORA (onset at &amp;lt;65\u2009years). The primary outcomes were changes in Clinical Disease Activity Index (CDAI) and Japanese version of the Health Assessment Questionnaire (J-HAQ) at Year 5. The secondary outcomes included the incidence of prespecified adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Methotrexate, biological disease-modifying anti-rheumatic drugs, and glucocorticoids were used in 70.6, 8.4 and 38.0% of the LORA group (n\u2009=\u2009813, median age: 71\u2009years), and 81.6, 19.4 and 32.0% of the YORA group (n\u2009=\u20092457, median age: 51\u2009years). Both groups exhibited significant initial improvements in CDAI and J-HAQ scores. At Year 5, mean CDAI scores were 4.39 and 4.03 for the LORA and YORA groups, respectively. J-HAQ score for YORA remained stable below 0.5 after Year 2, whereas that for LORA worsened progressively. At Year 5, mean J-HAQ scores were 0.56 for LORA and 0.33 for YORA. Patients with LORA had a higher incidence of adverse events, with adjusted hazard ratios of 4.70 for death and 2.58 for malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with LORA and YORA exhibited similar improvements in disease activity over 5\u2009years; however, those with LORA demonstrated a more pronounced decline in physical function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae673","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T07:28:41Z","timestamp":1734074921000},"page":"2541-2549","source":"Crossref","is-referenced-by-count":8,"title":["Higher risk of poor functional outcome and unfavourable clinical events for late-onset rheumatoid arthritis: results from the IORRA cohort"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-5500","authenticated-orcid":false,"given":"Naohiro","family":"Sugitani","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2850-326X","authenticated-orcid":false,"given":"Eiichi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]},{"name":"Showa University Research Administration Center, Showa University , Shinagawa-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Sugano","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Saka","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeko","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Ikari","sequence":"additional","affiliation":[{"name":"Section of Surgery for Inflammatory Joint Diseases, Department of Orthopedic Surgery, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Rheumatology, Sanno Medical Center , Minato-ku,","place":["Japan"]},{"name":"Department of Rheumatology, International University of Health and Welfare , Narita City,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine , Shinjuku-ku,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"2025050316140744600_keae673-B1","author":"United Nations","year":"2022"},{"key":"2025050316140744600_keae673-B2","author":"Portal Site of Official Statistics of Japan"},{"key":"2025050316140744600_keae673-B3","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/1756-185X.13974","article-title":"Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan","volume":"23","author":"Nakajima","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2025050316140744600_keae673-B4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrrheum.2013.92","article-title":"The influence of ageing on the development and management of rheumatoid arthritis","volume":"9","author":"Boots","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"2025050316140744600_keae673-B5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s40266-022-00976-5","article-title":"Difficult-to-treat rheumatoid arthritis in older adults: implications of ageing for managing patients","volume":"39","author":"Novella-Navarro","year":"2022","journal-title":"Drugs Aging"},{"key":"2025050316140744600_keae673-B6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40266-015-0341-2","article-title":"Targeting low disease activity in elderly-onset rheumatoid arthritis: current and future roles of biological disease-modifying antirheumatic drugs","volume":"33","author":"Sugihara","year":"2016","journal-title":"Drugs Aging"},{"key":"2025050316140744600_keae673-B7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/1756-185X.12998","article-title":"The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study","volume":"20","author":"Kato","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2025050316140744600_keae673-B8","first-page":"S49","article-title":"Elderly onset rheumatoid arthritis: clinical aspects","volume":"18","author":"Bajocchi","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"2025050316140744600_keae673-B9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jbspin.2015.09.010","article-title":"Effect of age at rheumatoid arthritis onset on clinical, radiographic, and functional outcomes: the ESPOIR cohort","volume":"83","author":"Krams","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2025050316140744600_keae673-B10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/rheumatology\/ket399","article-title":"Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort","volume":"53","author":"Mueller","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316140744600_keae673-B11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40744-020-00267-8","article-title":"Features and outcomes of elderly rheumatoid arthritis: does the Age of onset matter? A comparative study from a single center in China","volume":"8","author":"Ke","year":"2021","journal-title":"Rheumatol Ther"},{"key":"2025050316140744600_keae673-B12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/mr\/roab087","article-title":"Treatment strategies for elderly-onset rheumatoid arthritis in the new era","volume":"32","author":"Sugihara","year":"2022","journal-title":"Mod Rheumatol"},{"key":"2025050316140744600_keae673-B13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/mr\/roae011","article-title":"Consensus statement on the management of late-onset rheumatoid arthritis","volume":"34","author":"Kojima","year":"2024","journal-title":"Mod Rheumatol"},{"key":"2025050316140744600_keae673-B14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/mr\/roae026","article-title":"Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis","volume":"34","author":"Sugihara","year":"2024","journal-title":"Mod Rheumatol"},{"key":"2025050316140744600_keae673-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2019.1660028","article-title":"A large observational cohort study of rheumatoid arthritis, IORRA: providing context for today\u2019s treatment options","volume":"30","author":"Yamanaka","year":"2020","journal-title":"Mod Rheumatol"},{"key":"2025050316140744600_keae673-B16","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025050316140744600_keae673-B17","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/ar1740","article-title":"Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score","volume":"7","author":"Aletaha","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2025050316140744600_keae673-B18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.11465","article-title":"Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis","volume":"49","author":"Matsuda","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025050316140744600_keae673-B19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","article-title":"Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score","volume":"49","author":"van der Heijde","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"2025050316140744600_keae673-B20","doi-asserted-by":"crossref","first-page":"i28","DOI":"10.1136\/ard.59.suppl_1.i28","article-title":"Clinical outcome measures in rheumatoid arthritis","volume":"59","author":"van Riel","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"2025050316140744600_keae673-B21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316140744600_keae673-B22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.semarthrit.2020.03.018","article-title":"Treatment-resistant synovitis and radiographic progression are increased in elderly-onset rheumatoid arthritis patients: findings from a prospective observational longitudinal early arthritis cohort study","volume":"50","author":"Rom\u00e3o","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025050316140744600_keae673-B23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/1756-185X.13428","article-title":"Elderly onset of early rheumatoid arthritis is a risk factor for bone erosions, refractory to treatment: KURAMA cohort","volume":"22","author":"Murata","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2025050316140744600_keae673-B24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10067-021-05938-7","article-title":"Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study","volume":"41","author":"Furuya","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2025050316140744600_keae673-B25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10067-014-2750-8","article-title":"Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis","volume":"34","author":"Nakajima","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2025050316140744600_keae673-B26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/mr\/roac151","article-title":"Factors associated with impaired physical function in elderly rheumatoid arthritis patients who had achieved low disease activity","volume":"34","author":"Komiya","year":"2023","journal-title":"Mod Rheumatol"},{"key":"2025050316140744600_keae673-B27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00296-010-1638-4","article-title":"Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity","volume":"32","author":"Tanaka","year":"2012","journal-title":"Rheumatol Int"},{"key":"2025050316140744600_keae673-B28","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1038\/s41598-020-72274-2","article-title":"Association of age with the non-achievement of clinical and functional remission in rheumatoid arthritis","volume":"10","author":"Aoki","year":"2020","journal-title":"Sci Rep"},{"key":"2025050316140744600_keae673-B29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/joim.12853","article-title":"Erythrocyte sedimentation rate as an independent prognostic marker for mortality: a prospective population-based cohort study","volume":"285","author":"Fest","year":"2019","journal-title":"J Intern Med"},{"key":"2025050316140744600_keae673-B30","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3122\/jabfm.2021.05.210072","article-title":"C-Reactive protein versus erythrocyte sedimentation rate: implications among patients with no known inflammatory conditions","volume":"34","author":"Alende-Castro","year":"2021","journal-title":"J Am Board Fam Med"},{"key":"2025050316140744600_keae673-B31","doi-asserted-by":"crossref","first-page":"e0270977","DOI":"10.1371\/journal.pone.0270977","article-title":"A rapid and accurate method for estimating the erythrocyte sedimentation rate using a hematocrit-corrected optical aggregation index","volume":"17","author":"Higuchi","year":"2022","journal-title":"PLoS One"},{"key":"2025050316140744600_keae673-B32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1471-2474-15-368","article-title":"How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis","volume":"15","author":"Siemons","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"2025050316140744600_keae673-B33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/annrheumdis-2015-207511","article-title":"The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression","volume":"75","author":"Atsumi","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025050316140744600_keae673-B34","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3899\/jrheum.130365","article-title":"Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study","volume":"40","author":"Ajeganova","year":"2013","journal-title":"J Rheumatol"},{"key":"2025050316140744600_keae673-B35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/mr\/roab130","article-title":"Clinical observations of osteoporosis in Japanese patients with rheumatoid arthritis","volume":"32","author":"Furuya","year":"2022","journal-title":"Mod Rheumatol"},{"key":"2025050316140744600_keae673-B36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.21812","article-title":"Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis","volume":"65","author":"Widdifield","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025050316140744600_keae673-B37","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","article-title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis","volume":"71","author":"Dixon","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025050316140744600_keae673-B38","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/acr.21928","article-title":"Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study","volume":"65","author":"Veetil","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025050316140744600_keae673-B39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/s10165-008-0032-5","article-title":"Characteristics of fracture and related factors in patients with rheumatoid arthritis","volume":"18","author":"Nampei","year":"2008","journal-title":"Mod Rheumatol"},{"key":"2025050316140744600_keae673-B40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1302\/2046-3758.86.BJR-2018-0344.R1","article-title":"Tobacco and bone fractures: a review of the facts and issues that every orthopaedic surgeon should know","volume":"8","author":"Hernigou","year":"2019","journal-title":"Bone Joint Res"},{"key":"2025050316140744600_keae673-B41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/mr\/roac085","article-title":"Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: analyses from a 14-year observation of the IORRA cohort","volume":"33","author":"Sugimoto","year":"2023","journal-title":"Mod Rheumatol"},{"key":"2025050316140744600_keae673-B42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1248\/bpb.b18-00974","article-title":"Fragility fractures in older people in Japan based on the National Health Insurance claims database","volume":"42","author":"Iihara","year":"2019","journal-title":"Biol Pharm Bull"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae673\/61203891\/keae673.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/2541\/61203891\/keae673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/2541\/61203891\/keae673.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T16:14:27Z","timestamp":1746288867000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/5\/2541\/7925827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,12,16]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae673","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,16]]}}}